Literature DB >> 15616336

Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing.

Marjo Haanperä1, Pentti Huovinen, Jari Jalava.   

Abstract

A pyrosequencing method for detection and quantification of macrolide resistance mutations at positions 2058 and 2059 (Escherichia coli numbering) of the 23S rRNA gene is described. The method was developed and tested for Streptococcus pneumoniae, Streptococcus pyogenes, Mycobacterium avium, Campylobacter jejuni, and Haemophilus influenzae.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15616336      PMCID: PMC538907          DOI: 10.1128/AAC.49.1.457-460.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Rapid molecular identification and subtyping of Helicobacter pylori by pyrosequencing of the 16S rDNA variable V1 and V3 regions.

Authors:  H Monstein; S Nikpour-Badr; J Jonasson
Journal:  FEMS Microbiol Lett       Date:  2001-05-15       Impact factor: 2.742

3.  Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides.

Authors:  Anne-Laure Prunier; Brigitte Malbruny; Didier Tandé; Bertrand Picard; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

4.  A sequencing method based on real-time pyrophosphate.

Authors:  M Ronaghi; M Uhlén; P Nyrén
Journal:  Science       Date:  1998-07-17       Impact factor: 47.728

5.  Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.

Authors:  D O'Meara; K Wilbe; T Leitner; B Hejdeman; J Albert; J Lundeberg
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 6.  Erythromycin resistance by ribosome modification.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

7.  Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.

Authors:  A Tait-Kamradt; T Davies; M Cronan; M R Jacobs; P C Appelbaum; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

8.  Ribosomal mutations in Streptococcus pneumoniae clinical isolates.

Authors:  Marja Pihlajamäki; Janne Kataja; Helena Seppälä; John Elliot; Maija Leinonen; Pentti Huovinen; Jari Jalava
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

9.  Denaturing high-performance liquid chromatography detection of ribosomal mutations conferring macrolide resistance in gram-positive cocci.

Authors:  Annie Canu; Ahmed Abbas; Brigitte Malbruny; François Sichel; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  Mutation at the position 2058 of the 23S rRNA as a cause of macrolide resistance in Streptococcus pyogenes.

Authors:  Jari Jalava; Martti Vaara; Pentti Huovinen
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-05-06       Impact factor: 3.944

View more
  22 in total

Review 1.  From structure to function: the ecology of host-associated microbial communities.

Authors:  Courtney J Robinson; Brendan J M Bohannan; Vincent B Young
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

2.  Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology.

Authors:  Pontus Jureen; Lars Engstrand; Solveig Eriksson; Anders Alderborn; Margareta Krabbe; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.

Authors:  M Rantala; S Huikko; P Huovinen; J Jalava
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.

Authors:  Scott E Gygax; Jessica A Schuyler; Lauren E Kimmel; Jason P Trama; Eli Mordechai; Martin E Adelson
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

5.  Streptococcus pneumoniae isolates resistant to telithromycin.

Authors:  M Rantala; M Haanperä-Heikkinen; M Lindgren; H Seppälä; P Huovinen; J Jalava
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

6.  Pyrosequencing as a rapid tool for identification of GES-type extended-spectrum beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

7.  Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2.

Authors:  Marjo Haanperä; Jari Jalava; Pentti Huovinen; Olli Meurman; Kaisu Rantakokko-Jalava
Journal:  J Clin Microbiol       Date:  2007-01-10       Impact factor: 5.948

8.  Detection of azithromycin resistance in Treponema pallidum by real-time PCR.

Authors:  Mark W Pandori; Charmie Gordones; Lina Castro; Joseph Engelman; Mark Siedner; Sheila Lukehart; Jeffrey Klausner
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

9.  Detection of resistance to macrolides in thermotolerant campylobacter species by fluorescence in situ hybridization.

Authors:  Michaela Haas; Andreas Essig; Edda Bartelt; Sven Poppert
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

10.  Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155.

Authors:  C Hal Jones; Alexey Ruzin; Margareta Tuckman; Melissa A Visalli; Peter J Petersen; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.